CFDB - Cystic Fibrosis DataBase

primary studies published, non RCT

Early assessment of glucose abnormalities during continuous glucose monitoring associated with lung function impairment in cystic fibrosis patients.

Study design (if review, criteria of inclusion for studies)

Observational study

Participants

CF patients, aged 10years and over, with normal screening OGTT results (blood glucose at T120min<7.8mmol/l). Two groups were identified according to the max continuous glucose monitoring (CGM) glucose value: Group 1<11mmol/l and Group 2>/=11mmol/l. Among the 38 patients with normal OGTT, 12 (31.6%) were in Group 2.

Interventions

Continuous glucose monitoring (CGM). Two groups were identified according to the max CGM glucose value: Group 1<11mmol/l and Group 2>/=11mmol/l.

Outcome measures

Early glucose tolerance abnormalities; lung function and nutritional status

Main results

Among the 38 patients with normal OGTT, 12 (31.6%) were in Group 2. Compared to Group 1, Group 2 patients exhibited a significant impairment in lung function: FEV1, 68.2+/-25.6% vs. 87.3+/-17%, p=0.01 and FVC, 86.1%+/-19.4% vs. 99.3%+/-13.4%, p=0.021, as well as a higher rate of colonization by P. aeruginosa: 83.3% vs. 44%, p=0.024. Nevertheless, there were no differences in nutritional status (BMI standard deviation score: p=0.079; prealbumin: p=0.364).

Authors' conclusions

CGM reveals early abnormalities of glucose tolerance that remain undiagnosed by OGTT screening and are associated with worse lung function and a higher prevalence of P. aeruginosa colonization in patients with CF.

Keywords: continuous glucose monitoring (CGM); diagnostic procedures; non pharmacological intervention - diagn;